Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesElectrical muscle stimulation in thomboprophylaxis: review and a derived hypothesis about thrombogenesis-the 4th factorMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsSalivary Thromboxane A2-Binding Proteins from Triatomine Vectors of Chagas Disease Inhibit Platelet-Mediated Neutrophil Extracellular Traps (NETs) Formation and Arterial ThrombosisFrom basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"Plasmodium falciparum infection induces expression of a mosquito salivary protein (Agaphelin) that targets neutrophil function and inhibits thrombosis without impairing hemostasisCoagulation and morbidity in treated HIV infection.Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortiumThe simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Fibronectin maintains the balance between hemostasis and thrombosis.Propagation of thrombosis by neutrophils and extracellular nucleosome networks.Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians.Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis.Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis.Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis.Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium.
P2860
Q26739670-F4BC5D4B-806B-4BAA-8A01-267B8B293F3CQ26744129-C263C9B0-1A2B-432C-9766-319C84F812ABQ27024262-D1A0E784-1630-4E6E-99BA-56066B240D0DQ27304420-0648BD89-B16A-4FC2-96C1-201ADFDA272EQ28073354-3B3FB72E-C2DC-42AF-8A46-0E24C5FD0957Q30410705-AC3EDA29-DC00-4F59-9F3B-00895AA1F6EFQ33614424-03054FFC-0166-4FCC-8A6A-C34E8695406BQ33748053-A7CFCE53-EA47-4F63-B4C7-6065D965072EQ35043172-968FDAEE-159A-46E5-A0E0-1BD6CA3966C7Q36915078-A494FECD-7D6D-4CB8-B5AA-9A6A2CE19F5AQ38261764-48F5108D-3CA6-4A6F-8F93-8C88182CFE69Q38813246-DE05A157-77ED-48A9-AA5C-484FACD69630Q39032238-DFCC10A9-495D-44C8-983E-D6695D948E6FQ39449671-0BD3428F-27B3-4FD7-A98B-DD580B2CA4E5Q41124163-ADC035C8-64F3-4A84-A08B-EA1C6E40B956Q42355573-E234F096-16A2-412C-B401-D30FC8FD1DB7Q48087925-64C28A59-BBCA-4399-830B-2FC6545CC441Q49470799-FEBFBF38-7A78-4DB3-8AC0-7D0DB349BCE7Q50064062-6F4FA163-4243-4E10-87C4-9F993ECA95A7Q50088353-67BA6314-7105-44E2-95D2-9521316566DBQ54277572-9D4CAC4D-783D-483F-88A5-D1F8E4DA863A
P2860
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@ast
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@en
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@nl
type
label
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@ast
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@en
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@nl
prefLabel
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@ast
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@en
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@nl
P2093
P2860
P3181
P356
P1476
Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
@en
P2093
B. Engelmann
S. Massberg
P2860
P304
P3181
P356
10.1111/JTH.12261
P407
P478
11 Suppl 1
P577
2013-06-01T00:00:00Z